164 related articles for article (PubMed ID: 38809874)
1. Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis.
Soh J; Kim Y; Shen J; Kang M; Chaudhry S; Chung TH; Kim SH; Hwang Y; Lim D; Khattak A; Frimer L; Yoo JW
PLoS One; 2024; 19(5):e0303205. PubMed ID: 38809874
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL
Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
Hernandez JM; Paty J; Price IM
CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
[TBL] [Abstract][Full Text] [Related]
4. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada.
Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL
JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372
[TBL] [Abstract][Full Text] [Related]
5. Changes in Emergency Department Encounters for Vomiting After Cannabis Legalization in Colorado.
Wang GS; Buttorff C; Wilks A; Schwam D; Tung G; Pacula RL
JAMA Netw Open; 2021 Sep; 4(9):e2125063. PubMed ID: 34533572
[TBL] [Abstract][Full Text] [Related]
6. Hair cannabinoid concentrations in emergency patients with cannabis hyperemesis syndrome.
Albert K; Sivilotti MLA; Gareri J; Day A; Ruberto AJ; Hookey LC
CJEM; 2019 Jul; 21(4):477-481. PubMed ID: 30806339
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid hyperemesis syndrome: prevalence and management in an era of cannabis legalization.
Stubbs JJ; McCallum R
J Investig Med; 2024 Feb; 72(2):171-177. PubMed ID: 37997432
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid hyperemesis syndrome.
Heise L
Adv Emerg Nurs J; 2015; 37(2):95-101. PubMed ID: 25929220
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department.
Borgundvaag B; Bellolio F; Miles I; Schwarz ES; Sharif S; Su MK; Baumgartner K; Liss DB; Sheikh H; Vogel J; Austin EB; Upadhye S; Klaiman M; Vellend R; Munkley A; Carpenter CR
Acad Emerg Med; 2024 May; 31(5):425-455. PubMed ID: 38747203
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort.
Weiss J; Torrents R; Verhamme B; Roch A; Lazerges P; Jego M; Michelet P; Simon N
Fundam Clin Pharmacol; 2021 Feb; 35(1):186-191. PubMed ID: 32564375
[TBL] [Abstract][Full Text] [Related]
11. Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome.
Wightman RS; Metrik J; Lin TR; Li Y; Badea A; Almeida R; Collins AB; Beaudoin FL
Ann Emerg Med; 2023 Aug; 82(2):121-130. PubMed ID: 37479395
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment.
Leu N; Routsolias JC
J Emerg Nurs; 2021 May; 47(3):483-486. PubMed ID: 33712244
[TBL] [Abstract][Full Text] [Related]
13. Cannabis hyperemesis syndrome: Incidence and treatment with topical capsaicin.
Burillo-Putze G; Trujillo-Burillo D; García-Hernandez JC; López-Hernández MA; Hernández-Ramos I; Ramos-Suárez I; Richards JR
Med Clin (Barc); 2022 Aug; 159(4):183-186. PubMed ID: 34756408
[TBL] [Abstract][Full Text] [Related]
14. The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.
Myran DT; Pugliese M; Tanuseputro P; Cantor N; Rhodes E; Taljaard M
Addiction; 2022 Jul; 117(7):1952-1960. PubMed ID: 35170149
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid hyperemesis: a case series.
Donnino MW; Cocchi MN; Miller J; Fisher J
J Emerg Med; 2011 Apr; 40(4):e63-6. PubMed ID: 19765941
[TBL] [Abstract][Full Text] [Related]
16. Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization.
Myran DT; Gaudreault A; Pugliese M; Manuel DG; Tanuseputro P
JAMA Netw Open; 2023 Sep; 6(9):e2331551. PubMed ID: 37672273
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid hyperemesis and pheochromocytoma hypertensive urgency: a case report.
Arendash JM; Chiu C; Wang J; Mihm F
J Med Case Rep; 2024 Mar; 18(1):161. PubMed ID: 38500192
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence.
Andrews CN; Rehak R; Woo M; Walker I; Ma C; Forbes N; Rittenbach K; Hathaway J; Wilsack L; Liu A; Nasser Y; Sharkey KA
Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1532-1542. PubMed ID: 36307209
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
[No Abstract] [Full Text] [Related]
20. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
Desjardins N; Jamoulle O; Taddeo D; Stheneur C
J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
